Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -5921.09% is 17% below its 5-year average of -5075.88%, around the middle of its 5-year range (-10397.00%–-2423.44%).
8.95% above its 12-month average of -6502.92%.
Reported quarterly EBITDA margin; no daily interpolation. Q1 FY2026 (2026-03-31): -8830.15%.
EBITDA MARGIN
-5921.09%
EBITDA MARGIN AVG TTM
-6502.92%
EBITDA MARGIN AVG 3Y
-5526.43%
EBITDA MARGIN AVG 5Y
-5075.88%
EBITDA MARGIN AVG 10Y
-3785.81%
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+8.95%
CURRENT VS 3Y AVG
-7.14%
CURRENT VS 5Y AVG
-16.65%
CURRENT VS 10Y AVG
-56.40%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Silo Pharma, Inc.
Market Cap
$1.64M
EBITDA Margin
-5921.09%
TTM Avg
-6502.92%
3Y Avg
-5526.43%
5Y Avg
-5075.88%
Market Cap
$1.52M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.49M
EBITDA Margin
-1231.39%
TTM Avg
-651.84%
3Y Avg
-512.06%
5Y Avg
-24032.93%
Market Cap
$1.47M
EBITDA Margin
-22.87%
TTM Avg
-29.13%
3Y Avg
-70.31%
5Y Avg
-127.65%
Market Cap
$1.81M
EBITDA Margin
-84360.00%
TTM Avg
-66230.00%
3Y Avg
-193151.74%
5Y Avg
-158287.83%
Market Cap
$1.46M
EBITDA Margin
-346.64%
TTM Avg
-376.56%
3Y Avg
-438.06%
5Y Avg
-395.70%
Market Cap
$1.84M
EBITDA Margin
-337.86%
TTM Avg
-721.78%
3Y Avg
-2225.62%
5Y Avg
-2299.31%
Market Cap
$1.84M
EBITDA Margin
-310.90%
TTM Avg
-355.50%
3Y Avg
-975.40%
5Y Avg
-1515.38%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Silo Pharma, Inc. (SILO) | $1.64M | -5921.09% | -6502.92% | -5526.43% | -5075.88% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.52M | N/A | N/A | N/A | N/A |
| PMGC Holdings Inc. (ELAB)vs › | $1.49M | -1231.39% | -651.84% | -512.06% | -24032.93% |
| NEXGEL, Inc. (NXGL)vs › | $1.47M | -22.87% | -29.13% | -70.31% | -127.65% |
| Alaunos Therapeutics, Inc. (TCRT)vs › | $1.81M | -84360.00% | -66230.00% | -193151.74% | -158287.83% |
| Curis, Inc. (CRIS)vs › | $1.46M | -346.64% | -376.56% | -438.06% | -395.70% |
| Profusa, Inc. Common Stock (PFSA)vs › | $1.83M | N/A | N/A | N/A | N/A |
| Beyond Air, Inc. (XAIR)vs › | $1.84M | -337.86% | -721.78% | -2225.62% | -2299.31% |
| Tenon Medical, Inc. (TNON)vs › | $1.84M | -310.90% | -355.50% | -975.40% | -1515.38% |
| INVO Fertility, Inc. (IVF)vs › | $1.42M | -75.46% | -92.89% | -421.55% | -389.33% |
Gross Margin
-1128.9%
EBITDA Margin
-5921.1%
Operating Margin
-5936.9%
Net Margin
-8269.5%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-03-31 | -8830.15% |
| 2025-12-31 | -4346.98% |
| 2025-09-30 | -6371.86% |
| 2025-06-30 | -6913.05% |
| 2025-03-31 | -6052.53% |
| 2024-12-31 | -10397.00% |
| 2024-09-30 | -5586.48% |
| 2024-06-30 | -5563.24% |
| 2024-03-31 | -4879.14% |
| 2023-12-31 | -6143.56% |
| 2023-09-30 | -4290.70% |
| 2023-06-30 | -6185.77% |
| 2023-03-31 | -4457.37% |
| 2022-12-31 | -9192.04% |
| 2022-09-30 | -5265.76% |
| 2022-06-30 | -2742.22% |
| 2022-03-31 | -3344.66% |
| 2021-12-31 | -5228.09% |
| 2021-09-30 | -2573.88% |
| 2021-06-30 | -2423.44% |
| 2021-03-31 | -5242.82% |
| 2020-12-31 | -3528.09% |
| 2020-09-30 | -3367.53% |
| 2020-06-30 | -44977.12% |
| 2020-03-31 | -54203.40% |
| 2019-12-31 | -729.55% |
| 2019-09-30 | -90487.69% |
| 2018-12-31 | -344763.64% |
| 2018-09-30 | 199077.78% |
| 2018-06-30 | -68.28% |
| 2018-03-31 | -88.48% |
| 2017-12-31 | -25.32% |
| 2017-09-30 | -79.77% |
| 2017-06-30 | -4149.44% |
| 2017-03-31 | -15.53% |
| 2016-12-31 | -13.92% |
| 2016-09-30 | -79.14% |
| 2016-06-30 | -56.77% |
| 2016-03-31 | -484.88% |
| 2015-09-30 | -94.62% |
| 2015-06-30 | -77.13% |
| 2015-03-31 | -63.06% |
| 2014-12-31 | -4212.81% |
| 2014-09-30 | -22.92% |
| 2014-06-30 | -94.86% |
| 2014-03-31 | -6.50% |
| 2013-12-31 | -19.79% |
